From owner-metabolic-reg@net.bio.net Mon Sep 27 06:16:00 1999
Path: biosci!newsfeed.stanford.edu!arclight.uoregon.edu!hammer.uoregon.edu!newsfeed.direct.ca!hermes.visi.com!news-out.visi.com!feeder.qis.net!newsfeed1.earthlink.net!nntp.earthlink.net!posted-from-earthlink!not-for-mail
From: "Sini B." <bsini@earthlink.net>
Newsgroups: bionet.metabolic-reg
Subject: Co Enzyme Q
Date: Mon, 27 Sep 1999 00:00:08 -0700
X-ELN-Insert-Date: Mon Sep 27 00:05:18 1999
X-Newsreader: Microsoft Outlook Express 4.72.3110.5
Organization: EarthLink Network, Inc.
X-Posted-Path-Was: not-for-mail
Lines: 8
NNTP-Posting-Host: ip27.san-francisco28.ca.pub-ip.psi.net
X-MimeOLE: Produced By Microsoft MimeOLE V4.72.3110.3
X-ELN-Date: 27 Sep 1999 07:03:04 GMT
Message-ID: <7sn4r8$r2s$2@oak.prod.itd.earthlink.net>

Why "Co Enzyme Q" given for metasbolic disorder in infants? And under what
name is it marketed as?
Please provide us with some information,

Thanks in aadvance,
Sabu Yunnus




.